Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR
· Real-Time Price · USD
34.32
0.10 (0.29%)
At close: Jun 17, 2025, 3:59 PM
34.10
-0.64%
After-hours: Jun 17, 2025, 04:04 PM EDT
0.29% (1D)
| Bid | 33.95 |
| Market Cap | 209.87M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -3.94B |
| EPS (ttm) | -3.98 |
| PE Ratio (ttm) | -8.62 |
| Forward PE | -11.04 |
| Analyst | Buy |
| Ask | 36.11 |
| Volume | 6,145 |
| Avg. Volume (20D) | 23,873 |
| Open | 34.42 |
| Previous Close | 34.22 |
| Day's Range | 33.96 - 34.56 |
| 52-Week Range | 1.72 - 54.30 |
| Beta | 1.01 |
About MNPR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MNPR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MNPR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+7%
Monopar Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
6 months ago
+2.38%
Monopar Therapeutics shares are trading higher after the company announced it dosed its first patient with MNPR-101-Lu.
